Manzouri Bita, Dari Maria, Claoué Charles
Department of Ophthalmology, Queen's Hospital, BHR University Hospitals, London, England.
Institute of Health Sciences, Barts & The London School of Medicine & Dentistry, Queen Mary University of London, London, England.
Asia Pac J Ophthalmol (Phila). 2017 Jul-Aug;6(4):358-363. doi: 10.22608/APO.2017110. Epub 2017 Jun 26.
Supplemental intraocular lenses (IOLs) have been developed to replace IOLs designed for in-the-bag placement being used as "piggy-back" IOLs in the sulcus due to unacceptable complications. The new IOLs have unique platform designs to avoid these complications. As a result, a new nomenclature is needed to describe the 4 scenarios when supplemental IOL use is now indicated.
由于出现了不可接受的并发症,已开发出补充性人工晶状体(IOL),用于替代原本设计用于囊袋内植入、却在睫状沟用作“叠加式”人工晶状体的IOL。新型人工晶状体具有独特的平台设计以避免这些并发症。因此,需要一种新的命名法来描述现在表明需要使用补充性人工晶状体的4种情况。